Stroke prevention in atrial fibrillation: Do we still need warfarin?

Department of Neurology and Stroke Center, University Hospital Essen, University of Duisburg-Essen, Germany.
Current opinion in neurology (Impact Factor: 5.31). 12/2011; 25(1):27-35. DOI: 10.1097/WCO.0b013e32834e604a
Source: PubMed


Oral anticoagulation with vitamin K antagonists (warfarin, phenprocoumon) is successful in both primary and secondary stroke prevention in patients with atrial fibrillation, yielding a 60-70% relative reduction in stroke risk compared with placebo, as well as a mortality reduction of 26%. However, these agents have a number of well documented shortcomings. Acetylsalicylic acid (ASA) reduces the relative risk of stroke by a nonsignificant 19% compared with placebo, and increased bleeding risk offsets any therapeutic gain from the combination of ASA with clopidogrel. This review describes the current landscape and developments in stroke prevention in patients with atrial fibrillation, with special reference to secondary prevention.
A number of new drugs for oral anticoagulation that do not exhibit the limitations of vitamin K antagonists are under investigation. These include direct factor Xa inhibitors and direct thrombin inhibitors. Recent studies (RE-LY, ROCKET-AF, AVERROES, ARISTOTLE) provide promising results for new agents, including higher efficacy and significantly lower incidences of intracranial bleeds compared with warfarin. The new substances show similar results in secondary as in primary stroke prevention in patients with atrial fibrillation.
New anticoagulants add to the therapeutic options for patients with atrial fibrillation, and offer a number of advantages over warfarin, for both the clinician and patient, including a favourable bleeding profile and convenience of use. Consideration of these new anticoagulants will improve clinical decision making.

1 Follower
13 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Stroke seriously affects the quality of life (QoL) of elder people and leads to post-stroke mental disorder. It occurs when blood flow to a part of the brain is inadequate, leading to the death of brain cells. In China, the incidence of stroke is considered to be among the highest worldwide. Hence, in-depth research and understanding on the QoL of elder stroke patients is instructive to the nursing of stroke victims. Methods: The participants consisted of the stroke patients group (n=232) and the communitydwelling group (n=232). The QoL of both groups was measured using the ADL and the Medical Outcomes Study Short Form 36. Mental health was gauged using SAS and CES-D. Results: By comparing the results of the stroke and non-stroke groups, our study reveals that hypertension, high lipids, diabetes, heart disease, and atrial fibrillation are still the risk factors of stroke. The stroke group indicated significant results in general health (P=0.001), social functioning (P<0.001), physical functioning, (P<0.001) and more body pain (P<0.001) than the healthy group. Both groups manifested no symptom of depression and anxiety. However, the stroke group showed a stronger trend toward depression (P=0.01) and anxiety (P=0.04) than the non-stroke group. Conclusions: Study results indicate that elder stroke patients maintain a poorer QoL compared with elder non-stroke participants. No serious mental disorders were detected among the stroke patients who participated in our research. However, the stroke patients tended to be more depressed than the non-stroke elder persons.
    No preview · Article · Jan 2012 · Healthmed

  • No preview · Article · Jan 2012
  • [Show abstract] [Hide abstract]
    ABSTRACT: Catheter ablation of atrial fibrillation (AF) has evolved as a potential curative option for drug-refractory AF in recent years. AF not only causes physical morbidity but also jeopardizes the mental and social health of the patient as well as predisposing the patient to increased risk of thromboembolic events. Therefore, the primary end points of AF ablation have been restoration of sinus rhythm, improvement in the quality of life and lowering the risk of cerebrovascular accidents. However, even in the best hands, AF ablation is yet to be a total success. Several risk factors of AF and parameters of catheter ablation influence the short- and long-term ablation outcome. This article reviews all the information that has been contributed by prominent independent researchers over the last decade.
    No preview · Article · Jul 2012 · Expert Review of Cardiovascular Therapy
Show more